NF1

Clinical trials for NF1 explained in plain language.

Never miss a new study

Get alerted when new NF1 trials appear

Sign up with your email to follow new studies for NF1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

New drug cocktail shows promise for rare, aggressive sarcomas

Disease control Not yet recruiting

This study tests a combination of three drugs (selumetinib, ZEN-3694, and durvalumab) in people with advanced sarcomas, including a rare nerve tumor called MPNST. The goal is to see if the combination is safe and can shrink tumors or stop them from growing. About 41 adults with s…

Matched conditions: NF1

Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control

Last updated May 07, 2026 18:43 UTC

NF1

Get alerted when new NF1 trials appear

New drug cocktail shows promise for rare, aggressive sarcomas